GL Biochem (Shanghai) Ltd

GL Biochem (Shanghai) Ltd

Current Location: HOME >> Product
Product Categories
Country: China
Tel: 21-61263452
Mobile: 13641803416
E-mail:
QQ:
Skype: Chat Now!
Company Name:Shanghai GL Peptide Ltd
Tel:86-21-61263385
Fax:86-21-61263399
Email:ymbetter@glbiochem
WebSite:http://www.glbiochem.com
Nationality:CHINA
Product Name MF CAS Details
HIV-1 MN ENV-33;NCTDLRNTTNTNNST C62H105N23O29S Details
HIV-1 MN ENV-57;PAGFAILKCNDKKFS C75H119N19O20S Details
HIV-1 MN ENV-80;GRAFYTTKNIIGTIR C77H127N23O21 Details
HIV-1 MN ENV-4;WWGWGTMLLGLLMIC C86H126N18O17S3 Details
HIV-1 MN ENV-93;GGDPEIVMHSFNCGG C63H94N18O22S2 Details
HIV-1 MN ENV-90;FKNKTIVFNQSSGGD C72H112N20O24 Details
HIV-1 MN ENV-44;KMQKEYALLYKLDIV C87H143N19O23S Details
HIV-1 MN ENV-34;LRNTTNTNNSTANNN C62H105N25O28 Details
HIV-1 MN ENV-83;TIRQAHCNISRAKWN C76H124N28O21S Details
HIV-1 MN ENV-82;NIIGTIRQAHCNISR C70H122N26O21S Details
HIV-1 Protease Substrate, chromogenic;Ac-RKILF(4-NO2)LDG-NH2 C47H78N14O13 Details
HIV-1 MN ENV-77;NYNKRKRIHIGPGRA C77H130N30O19 Details
HIV-1 MN ENV-30;PCVKLTPLCVTLNCT C69H121N17O20S3 Details
HIV-1 MN ENV-211;LHIPTRIRQGLERAL C78H137N27O20 Details
HIV-1 MN ENV-79;HIGPGRAFYTTKNII C78H122N22O20 Details
HIV-1 MN ENV-85;ISRAKWNDTLRQIVS C78H131N25O23 Details
HIV-1 MN ENV-98;NTSPLFNSTWNGNNT C71H103N21O26 Details
HIV-1 MN ENV-47;DIVSIDNDSTSYRLI C73H119N19O28 Details
HIV-1 MN ENV-38;NSEGTIKGGEMKNCS C60H103N19O25S2 Details
HIV-1 MN ENV-60;KFSGKGSCKNVSTVQ C66H112N20O22S Details
HIV-1 MN ENV-31;LTPLCVTLNCTDLRN C70H122N20O23S2 Details
HIV-1 MN ENV-78;RKRIHIGPGRAFYTT C80H129N27O19 Details
HIV-1 MN ENV-46;LYKLDIVSIDNDSTS C73H119N17O28 Details
HIV-1 MN ENV-53;ACPKISFEPIPIHYC C80H120N18O20S2 Details
HIV-1 MN ENV-86;KWNDTLRQIVSKLKE C83H140N24O24 Details
HIV-1 MN ENV-87;TLRQIVSKLKEQFKN C82H142N24O23 Details
HIV-1 MN ENV-92;NQSSGGDPEIVMHSF C67H101N19O25S Details
HIV-1 MN ENV-36;NSTANNNSNSEGTIK C59H99N21O28 Details
HXB2 gag #102/aa405-419;CRAPRKKGCWKCGKE C73H124N26O18S3 Details
HIV-1 MN ENV-70;IRSENFTDNAKTIIV C75H125N21O25 Details
HIV-1 MN ENV-68;SLAEEEVVIRSENFT C74H119N19O28 Details
HIV-1 MN ENV-24;NMWKNNMVEQMHEDI C80H123N23O26S3 Details
HIV-1 MN ENV-58;AILKCNDKKFSGKGS C69H118N20O21S Details
HIV-1 MN ENV-39;TIKIGGEMKNCSFNIT C75H126N20O24S2 Details
HIV-1 MN gp160 Fragment 17;NDSTSYRLISCNTSV C67H110N20O27S Details
HIV-1 MN ENV-45;EYALLYKLDIVSIDN C82H129N17O26 Details
H-Tyr-Val-Ala-Asp-AFC;YVAD-AFC C31H34F3N5O9 Details
HIV-1 MN ENV-6;LGLLMICSATEKLWV C77H129N17O20S2 Details
HIV-1 MN ENV-22;LVNVTENFNMWKNNM C81H124N22O24S2 Details
HIV-1 MN ENV-32;CVTLNCTDLRNTTNT C65H113N21O26S2 Details
HXB2 gag #10;ASRELERFAVNPGLL Details
HIV-1 MN ENV-61;KGSCKNVSTVQCTHG C61H105N21O22S2 Details
HIV-1 MN ENV-81;YTTKNIIGTIRQAHC C74H123N23O22S Details
HIV-1 MN ENV-7;MICSATEKLWVTVYY C84H127N17O23S2 Details
HIV-1 MN ENV-54;ISFEPIPIHYCAPAG C76H111N17O20S Details
HIV-1 MN ENV-88;IVSKLKEQFKNKTIV C82H143N21O22 Details
HIV-1 MN ENV-25;NNMVEQMHEDIISLW C80H123N21O26S2 Details
HIV-1 MN ENV-50;RLISCNTSVITQACP C66H116N20O22S2 Details
HIV-1 MN gp160 Fragment 04;EKLWVYYGVPVWKEATTT C105H152N22O28 Details
HIV-1 MN gp160 Fragment 05;VPVWKEATTTLFCASDAKAY C101H153N23O30S Details
HIV-1 MN ENV-37;NNNSNSEGTIKGGEM C59H98N20O27S Details
HIV-1 MN ENV-5;GTMLLGLLMICSATE C66H117N15O21S3 Details
HIV-1 MN ENV-51;CNTSVITQACPKISF C69H114N18O22S2 Details
HIV-1 MN gp160 Fragment 03;CSATEKLWV C46H73N11O14S Details
HIV-1 MN ENV-62;KNVSTVQCTHGIRPV C69H119N23O21S Details
HIV-1 MN ENV-48;IDNDSTSYRLISCNT C69H112N20O28S Details
Human prepro-gamma-tryptase (192-206);CRRDYPGPGGSILQP C69H110N22O21S Details
HIV-1 MN ENV-99;LFNSTWNGNNTWNNT C78H107N23O26 Details
HIV-1 MN ENV-91;TIVFNQSSGGDPEIV C68H107N17O25 Details
HIV-1 MN ENV-59;CNDKKFSGKGSCKNV C66H111N21O22S2 Details
HIV-1 MN ENV-95;HSFNCGGEFFYCNTS C75H97N19O24S2 Details
HIV-1 MN ENV-97;FFYCNTSPLFNSTWN C87H113N19O24S Details
HIV-1 MN ENV-26;EQMHEDIISLWDQSL C80H122N20O28S Details
HIV-1 MN ENV-49;STSYRLISCNTSVIT C69H117N19O25S Details
HIV-1 MN ENV-75;VQINCTRPNYNKRKR C79H136N30O22S Details
HIV-1 MN ENV-41;NCSFNITTSIRDKMQ C72H120N22O25S2 Details
HIV-1 MN ENV-35;TNTNNSTANNNSNSE C57H92N22O31 Details
HIV-1 MN ENV-73;IIVHLNESVQINCTR C74H127N23O23S Details
HIV-1 MN gp160 Fragment 07;ELVNVTENFNMWK C73H110N18O22S Details
HIV-1 MN ENV-84;AHCNISRAKWNDTLR C75H121N27O22S Details
HIV-1 MN ENV-71;NFTDNAKTIIVHLNE C76H121N21O25 Details
HIV-1 MN ENV-96;CGGEFFYCNTSPLFN C77H103N17O23S2 Details
HIV-1 MN ENV-212;TRIRQGLERALL C61H112N22O17 Details
HIV-1 MN ENV-40;GEMKNCSFNITTSIR C70H117N21O24S2 Details
HIV-1 MN gp160 Fragment 15;REKMQKEYALLYKLDIVSID C111H183N27O33S Details
HIV-1 MN ENV-52;VITQACPKISFEPIP C76H123N17O21S Details
HIV-1 MN ENV-42;NITTSIRDKMQKEYA C76H128N22O26S Details
HIV-1 MN ENV-23;TENFNMWKNNMVEQM C81H122N22O26S3 Details
HIV-1 MN ENV-210;GRAILHIPTRIRQGL C75H133N27O18 Details
HIV-1 MN ENV-43;SIRDKMQKEYALLYK C85H140N22O24S Details
HXB2 gag #100/aa397-411;KEGHTARNCRAPRKK C71H126N30O20S Details
HIV-1 MN ENV-56;HYCAPAGFAILKCND C72H107N19O20S2 Details
H-Phe-Arg-AFC;FR-AFC C25H27F3N6O4 Details
HIV-1 MN ENV-21;QEVELVNVTENFNMW C82H122N20O27S Details
HIV-1 MN gp160 Fragment 02;LLMICSAT C36H66N8O11S2 Details
HMGA N-Terminal Fragment;GAGQPSTSAQGQ C42H69N15O19 Details
HIV-1 MN ENV-74;LNESVQINCTRPNYN C73H117N23O26S Details
HIV-1 MN ENV-8;ATEKLWVTVYYGVPV C84H125N17O22 Details
HIV-1 MN ENV-89;LKEQFKNKTIVFNQS C83H134N22O24 Details
HIV-1 MN ENV-72;NAKTIIVHLNESVQI C74H127N21O23 Details
HIV-1 MN gp160 Fragment 16;LYKLDIVSIDNDSTSYRLIS C103H167N25O35 Details
HIV-1 MN ENV-94;EIVMHSFNCGGEFFY C82H110N18O23S2 Details
HIV-1 MN ENV-69;EEVVIRSENFTDNAK C74H119N21O28 Details
HXB2 gag #103;RKKGCWKCGKEGHQM Details
HIV-1 MN gp160 Fragment 08;NFNMWKNNMVEQMHEDIISK C108H166N30O33S3 Details
HXB2 gag #101/aa401-415;TARNCRAPRKKGCWK C74H127N29O18S2 Details
Human Myocilin/TIGR Fragment (188-204);TRDTARAVPPGSREVST C73H126N26O27 Details
HXB2 gag #1/aa1-15;MGARASVLSGGELDR Details
HIV-1 MN ENV-3;NYQHWWGWGTMLLGL C90H120N22O20S Details
HIV-1 MN ENV-76;CTRPNYNKRKRIHIG C79H134N30O20S Details
Product Total: Product Page:
67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100